D
Voyageur Pharmaceuticals Ltd. VM.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

02/28/2025 11/30/2024 08/31/2024 05/31/2024 02/29/2024
Net Income -71.41% -27.70% 36.76% -68.59% -18.38%
Total Depreciation and Amortization -33.33% 0.00% 0.00% 0.00% -25.00%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 369.60% 281.01% -91.24% 91.81% 73.11%
Change in Net Operating Assets -303.47% 40.12% 154.08% 551.75% -92.30%
Cash from Operations -1,733.05% 828.40% 94.17% -1.91% -505.65%
Capital Expenditure -15.18% 36.07% -43.57% -0.36% -14.81%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -15.18% 36.07% -43.57% -0.36% -14.81%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -100.00% -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 143.27% 132.01% 1,497.22% 85.77% --
Cash from Financing 1,461.32% 107.84% 708.96% -101.92% 3,889.13%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 180.10% 1,695.95% 95.74% -194.19% 184,200.00%